Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease

Michael S. Leo, Raja K Sivamani

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The mechanistic target of rapamycin (mTOR) is involved in the regulation of cellular growth, proliferation, lipid synthesis, and protein translation. The mTOR pathway involves two complexes: the mechanistic target of rapamycin complex 1 (mTORC1) and the mechanistic target of rapamycin complex 2 (mTORC2). Both mTOR complexes have been implicated in the development and progression of various skin diseases including melanoma, psoriasis, and acne vulgaris. Here, we review the role of both mTORC1 and mTORC2 as well as their upstream modulators, phosphoinositide 3-kinase (PI3K) and protein kinase B (Akt), and their downstream targets in various dermatologic diseases. Phytochemicals, plant-derived naturally occurring compounds, have been shown to regulate the mTOR pathway and may serve as novel therapeutic agents in dermatological disease. Here, we review phytochemicals in the context of the mTOR pathway and their potential use in cutaneous disease.

Original languageEnglish (US)
Pages (from-to)861-871
Number of pages11
JournalArchives of Dermatological Research
Volume306
Issue number10
DOIs
StatePublished - Dec 1 2014

Fingerprint

Phytochemicals
Sirolimus
Skin Diseases
Dermatologic Agents
Proto-Oncogene Proteins c-akt
1-Phosphatidylinositol 4-Kinase
Acne Vulgaris
Protein Biosynthesis
Psoriasis
Melanoma
Cell Proliferation
Lipids
Growth
mechanistic target of rapamycin complex 1
TOR complex 2

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease. / Leo, Michael S.; Sivamani, Raja K.

In: Archives of Dermatological Research, Vol. 306, No. 10, 01.12.2014, p. 861-871.

Research output: Contribution to journalArticle

@article{28c1086b64da4b96afc400c5c711edd5,
title = "Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease",
abstract = "The mechanistic target of rapamycin (mTOR) is involved in the regulation of cellular growth, proliferation, lipid synthesis, and protein translation. The mTOR pathway involves two complexes: the mechanistic target of rapamycin complex 1 (mTORC1) and the mechanistic target of rapamycin complex 2 (mTORC2). Both mTOR complexes have been implicated in the development and progression of various skin diseases including melanoma, psoriasis, and acne vulgaris. Here, we review the role of both mTORC1 and mTORC2 as well as their upstream modulators, phosphoinositide 3-kinase (PI3K) and protein kinase B (Akt), and their downstream targets in various dermatologic diseases. Phytochemicals, plant-derived naturally occurring compounds, have been shown to regulate the mTOR pathway and may serve as novel therapeutic agents in dermatological disease. Here, we review phytochemicals in the context of the mTOR pathway and their potential use in cutaneous disease.",
author = "Leo, {Michael S.} and Sivamani, {Raja K}",
year = "2014",
month = "12",
day = "1",
doi = "10.1007/s00403-014-1480-8",
language = "English (US)",
volume = "306",
pages = "861--871",
journal = "Archives of Dermatological Research",
issn = "0340-3696",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Phytochemical modulation of the Akt/mTOR pathway and its potential use in cutaneous disease

AU - Leo, Michael S.

AU - Sivamani, Raja K

PY - 2014/12/1

Y1 - 2014/12/1

N2 - The mechanistic target of rapamycin (mTOR) is involved in the regulation of cellular growth, proliferation, lipid synthesis, and protein translation. The mTOR pathway involves two complexes: the mechanistic target of rapamycin complex 1 (mTORC1) and the mechanistic target of rapamycin complex 2 (mTORC2). Both mTOR complexes have been implicated in the development and progression of various skin diseases including melanoma, psoriasis, and acne vulgaris. Here, we review the role of both mTORC1 and mTORC2 as well as their upstream modulators, phosphoinositide 3-kinase (PI3K) and protein kinase B (Akt), and their downstream targets in various dermatologic diseases. Phytochemicals, plant-derived naturally occurring compounds, have been shown to regulate the mTOR pathway and may serve as novel therapeutic agents in dermatological disease. Here, we review phytochemicals in the context of the mTOR pathway and their potential use in cutaneous disease.

AB - The mechanistic target of rapamycin (mTOR) is involved in the regulation of cellular growth, proliferation, lipid synthesis, and protein translation. The mTOR pathway involves two complexes: the mechanistic target of rapamycin complex 1 (mTORC1) and the mechanistic target of rapamycin complex 2 (mTORC2). Both mTOR complexes have been implicated in the development and progression of various skin diseases including melanoma, psoriasis, and acne vulgaris. Here, we review the role of both mTORC1 and mTORC2 as well as their upstream modulators, phosphoinositide 3-kinase (PI3K) and protein kinase B (Akt), and their downstream targets in various dermatologic diseases. Phytochemicals, plant-derived naturally occurring compounds, have been shown to regulate the mTOR pathway and may serve as novel therapeutic agents in dermatological disease. Here, we review phytochemicals in the context of the mTOR pathway and their potential use in cutaneous disease.

UR - http://www.scopus.com/inward/record.url?scp=84936134638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936134638&partnerID=8YFLogxK

U2 - 10.1007/s00403-014-1480-8

DO - 10.1007/s00403-014-1480-8

M3 - Article

C2 - 24972910

AN - SCOPUS:84936134638

VL - 306

SP - 861

EP - 871

JO - Archives of Dermatological Research

JF - Archives of Dermatological Research

SN - 0340-3696

IS - 10

ER -